Kura Oncology
(KURA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,069 | -135,840 | -102,726 | -67,222 | -32,453 |
| Depreciation Amortization | -1,481 | 2,369 | 2,817 | 2,254 | 1,277 |
| Other Working Capital | -7,275 | -2,982 | -3,136 | -10,712 | -7,655 |
| Other Operating Activity | 6,953 | 26,391 | 19,513 | 13,158 | 6,650 |
| Operating Cash Flow | $-35,872 | $-110,062 | $-83,532 | $-62,522 | $-32,181 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 11,165 | 33,253 | 80,559 | 8,368 | -24,913 |
| PPE Investments | -36 | -626 | -614 | -233 | -49 |
| Investing Cash Flow | $11,129 | $32,627 | $79,945 | $8,135 | $-24,962 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 10,000 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 29,140 | 3,852 | 2,972 | 303 |
| Other Financing Activity | 0 | -575 | 0 | 0 | 0 |
| Financing Cash Flow | $N/A | $38,565 | $3,852 | $2,972 | $303 |
| Beginning Cash Position | 51,802 | 90,672 | 90,672 | 90,882 | 90,882 |
| End Cash Position | 27,059 | 51,802 | 90,937 | 39,467 | 34,042 |
| Net Cash Flow | $-24,743 | $-38,870 | $265 | $-51,415 | $-56,840 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,872 | -110,062 | -83,532 | -62,522 | -32,181 |
| Capital Expenditure | -36 | -626 | -614 | -233 | -49 |
| Free Cash Flow | -35,908 | -110,688 | -84,146 | -62,755 | -32,230 |